Xiamen Amoytop Biotech announced that director Lan Chun intends to reduce the company's shareholding by no more than 380,000 shares through centralized bidding and bulk transactions, accounting for no more than 0.093% of the company's total equity.
特宝生物：董事兰春拟减持不超38万股
Xiamen Amoytop Biotech: Director Lan Chun intends to reduce shareholdings by no more than 380,000 shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.